In addition, while serum ferritin concentration and transferrin saturation are useful for guiding clinical decisions regarding IV iron therapy, determining optimal iron status precisely in individual patients with CKD remains clinically challenging and necessitates further investigation [43]. The gene discussed is TF; the disease is chronic kidney disease.